Quadrant Capital Group LLC Has $99,000 Holdings in Embecta Corp. (NASDAQ:EMBC)

Quadrant Capital Group LLC trimmed its position in shares of Embecta Corp. (NASDAQ:EMBC) by 13.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,250 shares of the company’s stock after selling 835 shares during the period. Quadrant Capital Group LLC’s holdings in Embecta were worth $99,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Public Employees Retirement System of Ohio boosted its position in shares of Embecta by 66.2% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,284 shares of the company’s stock worth $34,000 after acquiring an additional 910 shares in the last quarter. Signaturefd LLC boosted its stake in Embecta by 1,254.4% in the third quarter. Signaturefd LLC now owns 2,316 shares of the company’s stock valued at $35,000 after buying an additional 2,145 shares in the last quarter. Bfsg LLC bought a new stake in shares of Embecta during the 4th quarter valued at approximately $53,000. NBC Securities Inc. acquired a new position in Embecta during the 3rd quarter worth approximately $44,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Embecta by 10.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,592 shares of the company’s stock valued at $174,000 after purchasing an additional 1,121 shares during the last quarter. 93.83% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Morgan Stanley lowered their price target on shares of Embecta from $16.00 to $13.00 and set an “underweight” rating for the company in a report on Friday, May 10th.

Embecta Trading Up 1.1 %

Shares of EMBC stock opened at $13.13 on Friday. The firm has a market capitalization of $757.21 million, a price-to-earnings ratio of 10.85 and a beta of 0.86. The business’s 50-day moving average price is $12.08 and its 200-day moving average price is $15.03. Embecta Corp. has a 12 month low of $9.93 and a 12 month high of $28.36.

Embecta (NASDAQ:EMBC) last posted its quarterly earnings data on Thursday, May 9th. The company reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.24. Embecta had a negative return on equity of 18.42% and a net margin of 6.20%. The business had revenue of $287.20 million during the quarter, compared to the consensus estimate of $264.70 million. During the same period in the prior year, the business posted $0.75 earnings per share. Embecta’s quarterly revenue was up 3.6% on a year-over-year basis. On average, sell-side analysts predict that Embecta Corp. will post 2.3 earnings per share for the current fiscal year.

Embecta Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Tuesday, May 28th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Friday, May 24th. This represents a $0.60 dividend on an annualized basis and a yield of 4.57%. Embecta’s dividend payout ratio (DPR) is currently 49.59%.

Embecta Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.